A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma

Clinical trial NCT01436656 · COMPLETED

Trial details

NCT number: NCT01436656
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma and Metastatic Colorectal Cancer

Start date: 2011-09-05
Primary completion: 2012-10-01
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.